Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study evaluates the clinical effect of foot injection of the bacteria protein Botulinum
toxin A on plantar pain in patients with EBS (epidermolysis bullosa simplex) or PC
(pachyonychia congenita).
Phase:
Phase 2
Details
Lead Sponsor:
Uppsala University
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA